[WEBINAR] What it takes to get a new drug to market in Australia

  1. 7,926 Posts.
    lightbulb Created with Sketch. 1230
    In this special event, learn of the processes that healthcare companies need to follow to attain approvals and how the trial phases work. In addition, gain valuable insights on whats moving the sector, as well as some of the most notable entities within the space.

    Join guest speakers from ASX healthcare companies, including:

    - Recce Pharmaceuticals (ASX:RCE): Chief Scientific Officer, Michele Dilizia
    - BlinkLab (ASX:BB1): Chairman, Brian Leedman
    - Race Oncology (ASX:RAC): CEO, Daniel Tillett
    - Bioshares: Editor, Mark Pachacz

    Attendees will also have the opportunity to take part in a liveQ+A with panel participants.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
45.5¢
Change
-0.020(4.21%)
Mkt cap ! $39.70M
Open High Low Value Volume
47.5¢ 48.5¢ 44.0¢ $79.18K 172.0K

Buyers (Bids)

No. Vol. Price($)
1 3088 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 28844 1
View Market Depth
Last trade - 15.38pm 28/07/2025 (20 minute delay) ?
BB1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.